Nucleai, an AI-powered spatial biology company, will present two abstracts at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting. The presentations will detail how Nucleai's AI-driven ...
The Company's liquid biopsy platform ... Poster presentation on Lobular Breast Cancer Research: BioMark's abstract entitled "Targeted Human Plasma Metabolomics for Lobular Breast Cancer Biomarker ...
ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") , an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, November 15, 2024, ...
Operator Good afternoon, everyone, and welcome to Gilead's third quarter 2024 earnings conference call. My name is Rebecca, and I'll be your host for today. In a moment, we'll begin with our prepared ...
Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...
Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET. Company Participants. Chris Taylor - Vice President, Investor Relations and ...
clinicaltrialsarena on MSN1d
Allurion boasts over 17% weight loss with swallowable balloon deviceThe data was presented as abstracts at the Obesity Society’s Obesity Week 2024 ... The drugs generated DKr41.6bn ($6bn) in ...
11hon MSN
Using its patented digital fingerprint technology, ProfilePrint can rapidly analyze the identity and quality of ingredients, ...
Skeletal stem cells have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of ...
Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback